Products for Research Use Only

IL8 Antibody Blocking peptide

CAT: 0013-GTR18961805Size: 500 µgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR18961805Size:500 µg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
IL8 Antibody Blocking peptide
Product Name Alternative
Interleukin-8, IL-8, C-X-C motif chemokine 8, Chemokine (C-X-C motif) ligand 8, Emoctakin, Granulocyte chemotactic protein 1, GCP-1, Monocyte-derived neutrophil chemotactic factor, MDNCF, Monocyte-derived neutrophil-activating peptide, MONAP, Neutrophil-activating protein 1, NAP-1, Protein 3-10C, T-cell chemotactic factor, MDNCF-a, GCP/IL-8 protein IV, IL8/NAP1 form I, Interleukin-8, (Ala-IL-8) 77, GCP/IL-8 protein II, IL-8 (1-77), IL8/NAP1 form II, MDNCF-b, IL-8 (5-77), IL-8 (6-77), (Ser-IL-8) 72, GCP/IL-8 protein I, IL8/NAP1 form III, Lymphocyte-derived neutrophil-activating factor, LYNAP, MDNCF-c, Neutrophil-activating factor, NAF, IL-8 (7-77), GCP/IL-8 protein V, IL8/NAP1 form IV, IL-8 (8-77), GCP/IL-8 protein VI, IL8/NAP1 form V, IL-8 (9-77), GCP/IL-8 protein III, IL8/NAP1 form VI, CXCL8, IL8
UniProt
P10145
Field of Research
Epigenetics, Immunology
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence used to generate the antibody orb1928399 was selected from the C-term region of human IL8. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Popular Products